A Randomized, Open-Label, Safety and Exploratory Efficacy Study of Kanglaite Injection (KLTi) plus Gemcitabine versus Gemcitabine in Patients with Advanced Pancreatic Cancer.

Schwartzberg, Lee S; Arena, Francis P; Bienvenu, Bryan J; Kaplan, Edward H; Camacho, Luis H; Campos, Luis T; Waymack, J Paul; Tagliaferri, Mary A; Chen, Michael M; Li, Dapeng

Schwartzberg, Lee S; Arena, Francis P; Bienvenu, Bryan J; Kaplan, Edward H; Camacho, Luis H; Campos, Luis T; Waymack, J Paul; Tagliaferri, Mary A; Chen, Michael M; Li, Dapeng.

Afiliação

Schwartzberg LS; West Cancer Center, Germantown, TN.
Arena FP; Arena Oncology Associates, New York, NY.
Bienvenu BJ; Mary Bird Perkins Cancer Center, Baton Rouge, LA.
Kaplan EH; Hematology Oncology of the North Shore, IL.
Camacho LH; St. Luke's Cancer Center, Houston, TX.
Campos LT; Oncology Consultants, Houston, TX.
Waymack JP; KangLaiTe USA, Redwood City, CA.
Tagliaferri MA; KangLaiTe USA, Redwood City, CA.
Chen MM; KangLaiTe USA, Redwood City, CA.
Li D; KangLaiTe USA, Redwood City, CA.

J Cancer ; 8(10): 1872-1883, 2017.

Article em En | MEDLINE | ID: mdl-28819385

Palavras-chave

Kanglaite Injection; coix seed; pancreatic cancer; traditional Chinese medicinal herb.

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2017 Tipo de documento: Article